Oncology & Hematology
Expertise: Oncology & Hematology 105 results
Oncology & Hematology
Building Effective Long-Term Follow-Up Strategies in Advanced Therapies
As cell and gene therapies continue to reshape treatment for complex and rare diseases, clinical research teams are navigating new operational realities. As these therapies advance, development strategies are also evolving to address new operational, regulatory, and evidence-generation challenges. Unlike many traditional therapies, cell and gene therapies may...
Oncology & Hematology
AACR
Oncology & Hematology
Operationalizing ADC Clinical Trials: Best Practices for Success
Oncology & Hematology
Operationalizing ADC Clinical Trials: Best Practices for Success
Oncology & Hematology
Operationalizing AI and RWE in Oncology: Converging Regulatory Landscapes
Artificial intelligence (AI) and real-world evidence (RWE) are playing a growing role across oncology development—from patient stratification and trial design to post-approval monitoring. As adoption accelerates, regulators are setting clearer expectations to ensure these tools are applied with transparency, rigor, and accountability. ...
Oncology & Hematology
Operationalizing ADC Clinical Trials: Dose, Safety, and Design
Antibody–drug conjugates (ADCs) are rapidly reshaping the oncology treatment landscape. By combining the targeting precision of monoclonal antibodies with the cytotoxic potency of small-molecule payloads, ADCs offer the promise of improved efficacy with more controlled toxicity. This potential has fueled...
Oncology & Hematology
Veronica Irving
Oncology & Hematology
AI and RWE: Powering the Future of Oncology
As the pace of innovation in oncology accelerates, artificial intelligence (AI) and real-world evidence (RWE) are reshaping how researchers understand disease, design studies, and deliver care. These technologies are bridging science, data, and clinical insight in ways that were once...
Oncology & Hematology